PLRX - Pliant Therapeutics, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - PLRX (1746473)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
36 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2024-01-17
PLRXCummings Keith LamontCFOS - Sale$17.23-9,781194,605-5%-$168,527
2024-01-17
PLRXHull HansChief Business OfficerS - Sale$17.23-9,786216,860-4%-$168,613
2024-01-17
PLRXCoulie BernardPres, CEOS - Sale$17.23-25,721725,699-3%-$443,173
2024-01-17
PLRXLefebvre EricChief Medical OfficerS - Sale$17.23-10,295156,920-6%-$177,383
2024-01-17
PLRXOuimette MikeGC, Corp. Sec'yS - Sale$17.23-5,19755,246-9%-$89,544
DM
2023-08-03
PLRXHull HansChief Business OfficerS - Sale+OE$20.01-34,919226,646-13%-$698,581
2023-07-20
PLRXOuimette MikeGC, Corp. Sec'yS - Sale$17.55-4,75560,443-7%-$83,450
2023-07-17
PLRXOuimette MikeGC, Corp. Sec'yS - Sale$18.01-12,77865,198-16%-$230,120
2023-07-17
PLRXLefebvre EricChief Medical OfficerS - Sale$18.01-22,321167,215-12%-$401,981
2023-07-17
PLRXHull HansChief Business OfficerS - Sale$18.01-17,937250,974-7%-$323,029
2023-07-17
PLRXCummings Keith LamontCFOS - Sale$18.01-19,771203,999-9%-$356,058
2023-07-17
PLRXCoulie BernardPres, CEOS - Sale$18.01-70,150751,420-9%-$1,263,338
M
2023-03-30
PLRXOuimette MikeGC, Corp. Sec'yS - Sale$26.62-7,75150,789-13%-$206,329
2023-03-30
PLRXLefebvre EricChief Medical OfficerS - Sale$26.52-11,245145,786-7%-$298,228
2023-03-30
PLRXHull HansChief Business OfficerS - Sale$26.52-9,036233,755-4%-$239,643
2023-03-30
PLRXCummings Keith LamontCFOS - Sale$26.52-9,960148,470-6%-$264,148
2023-03-30
PLRXCoulie BernardPres, CEOS - Sale$26.52-35,339684,070-5%-$937,222
DM
2023-02-02
PLRXCoulie BernardPres, CEOS - Sale+OE$33.91-30,000649,429-4%-$1,017,430
DM
2023-01-30
PLRXCoulie BernardPres, CEOS - Sale+OE$34.48-45,000649,429-6%-$1,551,637
DM
2023-01-26
PLRXCoulie BernardPres, CEOS - Sale+OE$35.32-55,000649,429-8%-$1,942,336
DM
2023-01-23
PLRXCoulie BernardPres, CEOS - Sale+OE$33.12-60,000528,129-10%-$1,987,473
D
2023-01-23
PLRXOuimette MikeGC, Corp. Sec'yS - Sale+OE$34.19-20,0005,947-77%-$683,878
2023-01-23
PLRXLefebvre EricChief Medical OfficerS - Sale$34.48-67,50076,926-47%-$2,327,630
D
2023-01-23
PLRXCummings Keith LamontCFOS - Sale+OE$35.00-30,00084,424-26%-$1,050,000
DM
2023-01-06
PLRXCoulie BernardPres, CEOS - Sale+OE$19.07-20,000543,129-4%-$381,413
DM
2023-01-03
PLRXCoulie BernardPres, CEOS - Sale+OE$19.20-30,000543,129-5%-$575,892
2022-12-22
PLRXOuimette MikeGC, Corp. Sec'yS - Sale$19.38-2,9285,947-33%-$56,731
2022-12-20
PLRXCummings Keith LamontCFOS - Sale$19.10-9,64380,424-11%-$184,204
2022-12-20
PLRXCoulie BernardPres, CEOS - Sale$19.10-34,212543,129-6%-$653,531
2022-12-20
PLRXLefebvre EricChief Medical OfficerS - Sale$19.10-10,887144,426-7%-$207,968
2022-12-20
PLRXOuimette MikeGC, Corp. Sec'yS - Sale$19.10-4,7198,875-35%-$90,144
2022-12-20
PLRXHull HansChief Business OfficerS - Sale$19.10-8,748169,982-5%-$167,108
2022-10-25
PLRXLefebvre EricChief Medical OfficerS - Sale$25.05-5,000133,437-4%-$125,241
D
2022-09-12
PLRXCoulie BernardPres, CEOS - Sale+OE$22.54-12,502508,590-2%-$281,851
2022-07-11
PLRXLefebvre EricChief Medical OfficerS - Sale$20.00-3,000138,436-2%-$60,000
DM
2022-07-11
PLRXCoulie BernardPres, CEOS - Sale+OE$22.50-27,498508,590-5%-$618,705

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top